D'Haens G, Danese S, Davies M, Watanabe M, et al. A phase II, Multicentre, Randomised, Double-Blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Efficacy of Amiselimod in Patients with Moderate to Severe Active Crohn's Disease. J Crohns Colitis 2022;16:746-756.
PMID: 34758080